Facebook
X
LinkedIn
ForwardLong Shots: HIV Prevention in 2025 & Beyond
Kentucky is among the states leading the country in HCV infections. It is critical for professionals to have current knowledge to provide effective treatment and education for patients. According to the CDC, Kentucky is at high risk for a HIV outbreak if introduced into the drug using population. HIV therapy was previously limited due to lack of treatment options, but more therapy options increase choice for patient treatment and challenges for providers. Screening for drug misuse is critical to the prevention of or early intervention in addiction.
"Long Shots: HIV Prevention in 2025 & Beyond" suggests a focus on breakthrough advancements and potential game-changers in the fight against HIV, particularly looking at strategies that offer long-lasting protection and go beyond current methods. However, achieving widespread impact requires overcoming financial, logistical, and social barriers to ensure equitable access to these crucial tools. The success of these advancements will depend on a combination of scientific innovation, dedicated funding, and coordinated efforts to address existing inequalities and make prevention accessible to all who need it.
Target Audience
Physicians, physician assistants, advanced practice nurses, nurses, pharmacists, dentists, social workers, health educators and therapists who currently provide or could provide care services to persons living with HIV/AIDS or Hepatitis C.
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Distinguish among currently available options for PrEP
2. Describe the logistical infrastructure needed to sustainably deliver long-acting injectable PrEP
3. Explain the mechanism of action of lenacapavir
4. Formulate an approach to counseling a hypothetical patient about the pros and cons of lenacapavir as PrEP
Faculty & Credentials
Christopher Hurt, MD, FIDSA
Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Disclosure Information
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
Christopher Hurt, MD faculty for this educational event, receives research funding from Gilead Sciences.
All of the relevant financial relationships listed for this individual has been mitigated. No other speakers, authors, planners or content reviewers have any relevant financial relationship to disclose
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.
- 1.00 Dentistry / Dental Hygiene (ADA) - University of Kentucky College of Dentistry
University of Kentucky College of Dentistry is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The University of Kentucky College of Dentistry designates the Fri, 07/18/2025 - 8:00am, activity for 1.00 hour(s) of continuing education credits.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Kentucky College of Dentistry and UK HealthCare CECentral.
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Enduring activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).
- 1.00 ASWB
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course.
Social workers completing this course receive 1.00 clinical continuing education credit(s).